V. Quaedvlieg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
V. Quaedvlieg has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
J. Sele
Department of Respiratory Medicine, GIGA Research Center, CHU Liege, I3 Group, University of Liege, Liege, Belgium
2 shared publicationsM. Henket
Department of Respiratory Medicine, GIGA Research Center, CHU Liege, I3 Group, University of Liege, Liege, Belgium
2 shared publicationsR. Louis
Department of Respiratory Medicine, GIGA Research Center, CHU Liege, I3 Group, University of Liege, Liege, Belgium
2 shared publications
Latest Publications
- 13 November 2009
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 39 (12) , 1822-1829
Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross‐sectional study in daily practice
Background The primary end‐point in the management of asthma is to obtain optimal control. The aim of this study was to assess the relationships between the markers of airway inflammation (sputum eosinophilia and exhaled nitric oxide), bronchial hyperresponsiveness (BHR) and asthma control. Methods One hundred and thirty‐four patients were recruited from our asthma clinic between January 2004 and September 2005 [mean age: 42 years, mean forced expiratory volume in 1 s (FEV1): 86% predicted]. Eighty‐six of them were treated by inhaled corticosteroids, 99 were atopic and 23 were current smokers. They all underwent detailed investigations including fractional‐exhaled nitric oxide (FENO) measurement, sputum induction and methacholine challenge when FEV1 was >70% predicted, and filled in a validated asthma control questionnaire (ACQ6 Juniper). Results When dividing patients into the three groups according to their level of asthma control determined by ACQ [well‐controlled asthma (ACQ score 0.75), borderline (0.75PPNO levels between the groups. With receiver‐operating characteristic curves for differentiating uncontrolled (ACQ1.5) from controlled and borderline (ACQNO (area under the curve: 0.72, 0.72 and 0.59, respectively). Conclusion In a broad spectrum of asthmatics encountered in clinical practice, sputum eosinophilia and methacholine bronchial hyperresponsiveness, but not FENO, are associated with uncontrolled asthma.
- 13 November 2009
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 39 (12) , 1822-1829
Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross‐sectional study in daily practice
Background The primary end‐point in the management of asthma is to obtain optimal control. The aim of this study was to assess the relationships between the markers of airway inflammation (sputum eosinophilia and exhaled nitric oxide), bronchial hyperresponsiveness (BHR) and asthma control. Methods One hundred and thirty‐four patients were recruited from our asthma clinic between January 2004 and September 2005 [mean age: 42 years, mean forced expiratory volume in 1 s (FEV1): 86% predicted]. Eighty‐six of them were treated by inhaled corticosteroids, 99 were atopic and 23 were current smokers. They all underwent detailed investigations including fractional‐exhaled nitric oxide (FENO) measurement, sputum induction and methacholine challenge when FEV1 was >70% predicted, and filled in a validated asthma control questionnaire (ACQ6 Juniper). Results When dividing patients into the three groups according to their level of asthma control determined by ACQ [well‐controlled asthma (ACQ score 0.75), borderline (0.75PPNO levels between the groups. With receiver‐operating characteristic curves for differentiating uncontrolled (ACQ1.5) from controlled and borderline (ACQNO (area under the curve: 0.72, 0.72 and 0.59, respectively). Conclusion In a broad spectrum of asthmatics encountered in clinical practice, sputum eosinophilia and methacholine bronchial hyperresponsiveness, but not FENO, are associated with uncontrolled asthma.
- Open Access
- 11 November 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 143 (1) , 161-166
Cytokine production from sputum cells in eosinophilicversusnon-eosinophilic asthmatics
The inflammatory pathways involved in asthma are more complex than the sole Th2‐mediated eosinophilic airway inflammation. Different phenotypes of asthma have been recently highlighted and are probably underlied by different immunological profiles. The aim of the study was to assess cytokine production from sputum cells in eosinophilic versus non‐eosinophilic asthmatics. Induced sputum was obtained from 48 consecutive stable mild to moderate asthmatics (20 eosinophilic asthmatics, 28 non‐eosinophilic asthmatics) and 31 healthy subjects. Cytokine released from sputum cells were measured by a home‐made two‐step sandwich immunoassay. Cytokines investigated were interleukin (IL)‐4, IL‐6, IL‐10, tumour necrosis factor (TNF)‐α and interferon (IFN)‐γ. Sputum cells from eosinophilic asthmatics produced more IL‐4 than those from both healthy subjects (P < 0·05) and non‐eosinophilic asthmatics (P < 0·05). Conversely, sputum cells from eosinophilic asthma were found to release lower amounts of TNF‐α than those from healthy subjects (P < 0·05). The group of non‐eosinophilic asthmatics did not distinguish from healthy subjects with respect to any cytokines measured. Sputum cells from asthmatics exhibiting eosinophilic airway inflammation release more IL‐4 and less TNF‐α than those of healthy subjects. By contrast, non‐eosinophilic asthmatics did not distinguish from healthy subjects by abnormal cytokine release from their sputum cells.
- 11 November 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 143 (1) , 161-166
Open AccessCytokine production from sputum cells in eosinophilicversusnon-eosinophilic asthmatics
The inflammatory pathways involved in asthma are more complex than the sole Th2‐mediated eosinophilic airway inflammation. Different phenotypes of asthma have been recently highlighted and are probably underlied by different immunological profiles. The aim of the study was to assess cytokine production from sputum cells in eosinophilic versus non‐eosinophilic asthmatics. Induced sputum was obtained from 48 consecutive stable mild to moderate asthmatics (20 eosinophilic asthmatics, 28 non‐eosinophilic asthmatics) and 31 healthy subjects. Cytokine released from sputum cells were measured by a home‐made two‐step sandwich immunoassay. Cytokines investigated were interleukin (IL)‐4, IL‐6, IL‐10, tumour necrosis factor (TNF)‐α and interferon (IFN)‐γ. Sputum cells from eosinophilic asthmatics produced more IL‐4 than those from both healthy subjects (P < 0·05) and non‐eosinophilic asthmatics (P < 0·05). Conversely, sputum cells from eosinophilic asthma were found to release lower amounts of TNF‐α than those from healthy subjects (P < 0·05). The group of non‐eosinophilic asthmatics did not distinguish from healthy subjects with respect to any cytokines measured. Sputum cells from asthmatics exhibiting eosinophilic airway inflammation release more IL‐4 and less TNF‐α than those of healthy subjects. By contrast, non‐eosinophilic asthmatics did not distinguish from healthy subjects by abnormal cytokine release from their sputum cells.